AFP welcomes European Commission decision securing its public financing

The European Commission has given its decision on a complaint made in February 2010 by a German news  agency against France for giving state aid to AFP. The decision recognizes the missions of general interest on an international level attributed to AFP and permits the compensation of the net cost by a State subsidy that respects European competition laws. “This decision is a crucial moment for AFP,” said AFP chairman Emmanuel Hoog.

The European Commission has given its decision on a complaint made in February 2010 by a German news  agency against France for giving state aid to AFP. The decision recognizes the missions of general interest on an international level attributed to AFP and permits the compensation of the net cost by a State subsidy that respects European competition laws. “This decision is a crucial moment for AFP,” said AFP chairman Emmanuel Hoog.
Anglais

AFP CEO conveys his condolences to Al Jazeera teams after the death of journalist Shireen Abu Akleh

Fabrice Fries, Chairman and CEO at AFP, has conveyed his condolences to Sheikh Hamad bin Thamer Al-Thani, Chairman of the Board for Al Jazeera media network, after the death of journalist Shireen Abu Akleh.

Fabrice Fries, Chairman and CEO at AFP, has conveyed his condolences to Sheikh Hamad bin Thamer Al-Thani, Chairman of the Board for Al Jazeera media network, after the death of journalist Shireen Abu Akleh.
07/21/2026 07:00
CapVest Completes Acquisition of TSG

CapVest Partners LLP (“CapVest”), a leading New York and London based investment firm, today announces that it has completed its acquisition of a majority stake in TSG Solutions (“TSG”), a European leader in technical services for critical energy infrastructure, following receipt of all necessary approvals. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260721628079/en/TSG Headquartered in Paris, France, TSG operates across 30 count...

07/21/2026 07:00
European Commission Approves Crysvita® (burosumab) for Infants with X-linked Hypophosphataemia in the European Union

Kyowa Kirin EMEA, a wholly owned subsidiary of Kyowa Kirin Co., Ltd. (TSE:4151), today announced that the European Commission (EC) has approved an expansion of the indication for Crysvita® (burosumab) for the treatment of X-linked hypophosphataemia (XLH), to include infants from 1 month to 1 year of age across the European Union and European Economic Area. The approval represents an important step forward for infants living with XLH, a rare, progressive genetic disease that can affect skeleta...

Subscribe to